| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.33▼ | 9.32▼ | 9.31▼ | 9.49▼ | 8.95▲ |
| MA10 | 9.34▼ | 9.31▼ | 9.36▼ | 9.31▼ | 8.92▲ |
| MA20 | 9.34▼ | 9.37▼ | 9.46▼ | 8.92▲ | 9.39▼ |
| MA50 | 9.31▼ | 9.45▼ | 9.45▼ | 8.87▲ | 7.34▲ |
| MA100 | 9.37▼ | 9.43▼ | 9.14▲ | 9.32▼ | 6.94▲ |
| MA200 | 9.46▼ | 9.09▲ | 8.93▲ | 7.88▲ | 9.83▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.005▼ | 0.000▼ | -0.025▼ | 0.070▲ | -0.116▼ |
| RSI | 44.269▼ | 42.628▼ | 43.293▼ | 53.822▲ | 54.087▲ |
| STOCH | 16.250▼ | 28.937 | 16.292▼ | 74.128 | 52.395 |
| WILL %R | -100.000▼ | -82.143▼ | -88.636▼ | -35.252 | -30.795 |
| CCI | -154.167▼ | -17.357 | -63.916 | 38.582 | 90.330 |
| MA | $AVXL Price Crossed Below MA(7) | Set Alert |
|
Thursday, May 01, 2025 04:30 AM
Study ANAVEX3-71-SZ-001 successfully completes enrollment with a total of 71 participants Both Part A (16 participants) and Part B (55 participants) of the placebo-controlled Phase 2 study fully ...
|
|
Wednesday, April 30, 2025 04:30 AM
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...
|
|
Tuesday, April 29, 2025 09:23 AM
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 9.40 | 9.50 | 9.25 | 9.31 | 764,029 |
| 30/04/25 | 9.40 | 9.6914 | 9.33 | 9.50 | 639,485 |
| 29/04/25 | 9.615 | 9.67 | 9.43 | 9.63 | 320,412 |
| 28/04/25 | 9.45 | 9.7195 | 9.3301 | 9.58 | 471,849 |
| 25/04/25 | 9.46 | 9.655 | 9.312 | 9.42 | 308,313 |
| 24/04/25 | 9.31 | 9.5822 | 9.27 | 9.45 | 472,226 |
| 23/04/25 | 9.47 | 9.80 | 9.26 | 9.31 | 976,270 |
| 22/04/25 | 8.90 | 9.24 | 8.78 | 9.21 | 698,715 |
| 21/04/25 | 8.87 | 9.2351 | 8.61 | 8.76 | 666,432 |
| 17/04/25 | 8.81 | 8.99 | 8.70 | 8.95 | 351,348 |
|
|
||||
|
|
||||
|
|